chr15-75917309-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_147188.3(FBXO22):ā€‹c.543A>Cā€‹(p.Gln181His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000754 in 1,458,352 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000075 ( 0 hom. )

Consequence

FBXO22
NM_147188.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.52
Variant links:
Genes affected
FBXO22 (HGNC:13593): (F-box protein 22) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and, as a transcriptional target of the tumor protein p53, is thought to be involved in degradation of specific proteins in response to p53 induction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08621687).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FBXO22NM_147188.3 linkuse as main transcriptc.543A>C p.Gln181His missense_variant 5/7 ENST00000308275.8 NP_671717.1 Q8NEZ5-1
FBXO22NM_012170.4 linkuse as main transcriptc.543A>C p.Gln181His missense_variant 5/6 NP_036302.1 Q8NEZ5-3
FBXO22XM_047432382.1 linkuse as main transcriptc.231A>C p.Gln77His missense_variant 4/6 XP_047288338.1
FBXO22NR_037623.2 linkuse as main transcriptn.490A>C non_coding_transcript_exon_variant 4/6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FBXO22ENST00000308275.8 linkuse as main transcriptc.543A>C p.Gln181His missense_variant 5/71 NM_147188.3 ENSP00000307833.3 Q8NEZ5-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000200
AC:
5
AN:
250248
Hom.:
0
AF XY:
0.0000296
AC XY:
4
AN XY:
135324
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000164
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000754
AC:
11
AN:
1458352
Hom.:
0
Cov.:
28
AF XY:
0.0000110
AC XY:
8
AN XY:
725702
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000128
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 04, 2024The c.543A>C (p.Q181H) alteration is located in exon 5 (coding exon 5) of the FBXO22 gene. This alteration results from a A to C substitution at nucleotide position 543, causing the glutamine (Q) at amino acid position 181 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Benign
0.012
T;.;T
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.51
FATHMM_MKL
Benign
0.71
D
LIST_S2
Uncertain
0.88
D;D;D
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.086
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L;L;.
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.050
Sift
Benign
0.23
T;T;T
Sift4G
Benign
0.25
T;T;D
Polyphen
0.88
P;B;.
Vest4
0.25
MutPred
0.34
Gain of loop (P = 0.0851);Gain of loop (P = 0.0851);.;
MVP
0.082
MPC
1.1
ClinPred
0.34
T
GERP RS
0.53
Varity_R
0.051
gMVP
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs767105229; hg19: chr15-76209650; API